Vaccine regimen fails to prevent HIV-1 infection in South Africa
Researchers show how stem cell depletion leads to recurring pregnancy loss
25 March 2021Current smoking linked to increase in CHD risk in African-Americans
25 March 2021Vaccine regimen fails to prevent HIV-1 infection in South Africa
(HealthDay)—A canarypox-protein HIV vaccine regimen (ALVAC-HIV) plus bivalent subtype C gp120-MF59 adjuvant does not prevent HIV-1 infection among adults in South Africa, according to a study published in the March 25 issue of the New England Journal of Medicine.
